Market Cap
$14.47 B
+$482.95 M+3.45%
Tue, 31 Dec 2024 00:03:06 GMT
Summary:
Neurocrine Biosciences market capitalization is currently $14.47 billion, with a rise of +$482.95 million (+3.45%) during the most recent trading day. Over the past year, it has increased by +$1.43 billion (+10.95%). NBIX market cap is now -7.58% below its all-time high of $15.65 billion.NBIX Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Market Cap Performance
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | TTM Dividend per shareTTM Dividend per share |
|---|---|---|---|---|
| todaytoday | +3.5% | +3.5% | +0.1% | - |
| 1 m1 month | +12.7% | +12.7% | - | - |
| 3 m3 months | +29.1% | +29.0% | - | - |
| 6 m6 months | +5.8% | +5.4% | - | - |
| ytdytd | +10.4% | +7.7% | - | - |
| 1 y1 year | +10.9% | +7.7% | +3.1% | - |
| 5 y5 years | +46.6% | +33.3% | +10.0% | - |
NBIX Market Cap High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $14 B | at high | $13 B | +15.4% |
| 3 m | 3 months | $14 B | at high | $11 B | +29.1% |
| 6 m | 6 months | $16 B | -7.6% | $11 B | +29.1% |
| 1 y | 1 year | $16 B | -7.6% | $11 B | +29.1% |
| 3 y | 3 years | $16 B | -7.6% | $6.88 B | +110.4% |
| 5 y | 5 years | $16 B | -7.6% | $6.88 B | +110.4% |
| alltime | all time | $16 B | -7.6% | $73 M | >+9999.0% |
Neurocrine Biosciences Market Cap History
| Date | Value |
|---|---|
| 2024 | $14.47 B(+10.5%) |
| 2023 | $13.10 B(+13.6%) |
| 2022 | $11.53 B(+42.6%) |
| 2021 | $8.08 B(-9.8%) |
| 2020 | $8.96 B(-9.6%) |
| 2019 | $9.92 B(+53.0%) |
| 2018 | $6.48 B(-5.9%) |
| 2017 | $6.89 B(+104.9%) |
| 2016 | $3.36 B(-31.1%) |
| 2015 | $4.88 B(+185.7%) |
| 2014 | $1.71 B(+171.6%) |
| 2013 | $629.06 M(+26.6%) |
| 2012 | $497.02 M(+5.8%) |
| 2011 | $469.73 M(+12.0%) |
| Date | Value |
|---|---|
| 2010 | $419.30 M(+250.4%) |
| 2009 | $119.66 M(-3.1%) |
| 2008 | $123.51 M(-28.9%) |
| 2007 | $173.76 M(-56.0%) |
| 2006 | $394.98 M(-83.0%) |
| 2005 | $2.33 B(+29.3%) |
| 2004 | $1.80 B(-6.5%) |
| 2003 | $1.93 B(+37.6%) |
| 2002 | $1.40 B(-10.1%) |
| 2001 | $1.56 B(+85.7%) |
| 2000 | $838.54 M(+56.8%) |
| 1999 | $534.80 M(+310.9%) |
| 1998 | $130.15 M(-6.6%) |
| 1997 | $139.29 M(-24.2%) |
| 1996 | $183.70 M |
FAQ
- What is Neurocrine Biosciences market capitalization?
- What is the all time high market cap for Neurocrine Biosciences?
- What is NBIX market capitalization year-to-date change?
- What is Neurocrine Biosciences market cap year-on-year change?
What is Neurocrine Biosciences market capitalization?
The current market cap of NBIX is $14.47 B
What is the all time high market cap for Neurocrine Biosciences?
Neurocrine Biosciences all-time high market capitalization is $15.65 B
What is NBIX market capitalization year-to-date change?
Neurocrine Biosciences market capitalization has changed by +$1.37 B (+10.45%) since the beginning of the year
What is Neurocrine Biosciences market cap year-on-year change?
Over the past year, NBIX market capitalization has changed by +$1.43 B (+10.95%)